The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
VJVirtual | Unmet needs in the treatment of pediatric/adolescent MPN
Nicole Kucine, MD, MS, Weill Cornell Medicine, New York, NY, outlines unmet needs in the treatment and management of pediatric/adolescent myeloproliferative neoplasms (MPN), including when to begin cytoreductive treatment, what agents to use for young patients, and the importance of understanding what drives disease. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
